<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) disruption following <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> (<z:hpo ids='HP_0001297'>stroke</z:hpo>) contributes to the development of life-threatening <z:hpo ids='HP_0002181'>brain edema</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Recent studies suggested that the ischemic <z:chebi fb="2" ids="33602">BBB</z:chebi> disruption is not uniform throughout the affected brain region </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to establish in vivo optical imaging methods to assess the size selectivity and spatial distribution of the <z:chebi fb="2" ids="33602">BBB</z:chebi> disruption after a focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:chebi fb="2" ids="33602">BBB</z:chebi> permeability was assessed in mice subjected to a 60-min middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> and 24 h of reperfusion using in vivo time domain near-infrared optical imaging after contrast enhancement with two tracers of different molecular size, Cy5.5 (1 kDa) and Cy5.5 conjugated with bovine serum albumin (BSA) (67 kDa) </plain></SENT>
<SENT sid="4" pm="."><plain>Volumetric reconstruction of contrast-enhanced brain areas in vivo and ex vivo indicated that the BSA-Cy5.5-enhancement is identical to the volume of <z:mpath ids='MPATH_124'>infarct</z:mpath> determined by TTC staining, whereas the volume of enhancement with Cy5.5 was 40% greater </plain></SENT>
<SENT sid="5" pm="."><plain>The volume differential between areas of <z:chebi fb="2" ids="33602">BBB</z:chebi> disruption for small and large-size molecules could be useful for determining the size of peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> tissues (penumbra) that can respond to neuroprotective therapies </plain></SENT>
</text></document>